Adc Therapeutics Sa (ADCT)

09:40 AM

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - Yahoo Finance

09:40 AM

03:44 AM

ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

03:44 AM

Jan 12, 2026

ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy - TipRanks

Jan 12, 2026

Jan 10, 2026

How geopolitical tensions affect ADC Therapeutics SA stock2025 Sector Review & Technical Buy Zone Confirmations - Улправда

Jan 10, 2026

Jan 10, 2026

Can ADC Therapeutics SA Common Shares stock sustain margin levelsCEO Change & Low Drawdown Trading Techniques - Улправда

Jan 10, 2026

Jan 09, 2026

ADC Therapeutics posts preliminary 2025 revenue of about $73M - MSN

Jan 09, 2026

Jan 09, 2026

Is ADC Therapeutics SA Common Shares stock testing key supportQuarterly Market Review & Free High Accuracy Swing Entry Alerts - Улправда

Jan 09, 2026

Jan 09, 2026

ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Sahm

Jan 09, 2026

Jan 08, 2026

ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook - TipRanks

Jan 08, 2026

Jan 08, 2026

Can ADC Therapeutics SA stock rebound after recent weakness2025 Winners & Losers & Free Reliable Trade Execution Plans - Улправда

Jan 08, 2026

Jan 08, 2026

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - PR Newswire

Jan 08, 2026

Jan 07, 2026

ADC Therapeutics SA Common Shares (NY: ADCT - markets.financialcontent.com

Jan 07, 2026

Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC ... - Bluefield Daily Telegraph

Jan 06, 2026

Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - FinancialContent

Jan 06, 2026

Jan 06, 2026

Will ADC Therapeutics SA stock outperform international peers2026 world cup usa national team round of 32 top scorers high defensive line tactical prediction guide - ulpravda.ru

Jan 06, 2026

Jan 03, 2026

ADCT stock touches 52-week low at $1.42 amid market challenges - MSN

Jan 03, 2026

Jan 03, 2026

ADC Therapeutics Announces New Employee Inducement Grant - 富途牛牛

Jan 03, 2026

Dec 30, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company - GlobeNewswire Inc.

Dec 30, 2025

Dec 29, 2025

ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why - Yahoo Finance

Dec 29, 2025

Dec 29, 2025

Is ADC Therapeutics SA a good long term investmentOptions Trading Strategies & Free Take Advantage Of Momentum - earlytimes.in

Dec 29, 2025

Dec 27, 2025

Corient Private Wealth LLC Makes New Investment in ADC Therapeutics SA $ADCT - MarketBeat

Dec 27, 2025

Dec 19, 2025

Risk Report: Will ADC Therapeutics SA stock beat EPS estimatesQuarterly Profit Report & Fast Gaining Stock Reports - Улправда

Dec 19, 2025

Dec 19, 2025

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - marketscreener.com

Dec 19, 2025

Dec 19, 2025

Is ADC Therapeutics SA stock a contrarian buyJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда

Dec 19, 2025

Dec 19, 2025

ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 19, 2025

Dec 19, 2025

Will ADC Therapeutics SA stock beat EPS estimatesMarket Activity Report & Safe Entry Zone Identification - Улправда

Dec 19, 2025

Dec 18, 2025

Wall Street Recap: Is ADC Therapeutics SA Common Shares stock undervalued historically2025 EndofYear Setup & Weekly High Return Forecasts - Улправда

Dec 18, 2025

Dec 18, 2025

How buybacks impact ADC Therapeutics SA stock value2025 Investor Takeaways & Entry and Exit Point Strategies - Улправда

Dec 18, 2025

Dec 18, 2025

Is ADC Therapeutics SA Common Shares stock undervalued historically2025 Big Picture & Weekly Momentum Stock Picks - Улправда

Dec 18, 2025

Dec 18, 2025

RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development - Yahoo Finance

Dec 18, 2025

Dec 17, 2025

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - sharewise.com

Dec 17, 2025

Dec 15, 2025

ADC Therapeutics (NYSE:ADCT) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Dec 15, 2025

Dec 15, 2025

ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy? - sharewise.com

Dec 15, 2025

Dec 13, 2025

ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript - MSN

Dec 13, 2025

Dec 11, 2025

ADC Therapeutics SA Stock Analysis and ForecastHigh Beta Stocks & Predict Price Movements With AI Precision - earlytimes.in

Dec 11, 2025

Dec 09, 2025

CEO Mallik Surrenders 233,146 Of ADC Therapeutics SA [ADCT] - TradingView — Track All Markets

Dec 09, 2025

Dec 09, 2025

Officer Graham Surrenders 49,508 Of ADC Therapeutics SA [ADCT] - TradingView — Track All Markets

Dec 09, 2025

Dec 09, 2025

ADC Therapeutics (NYSE: ADCT) CEO reports 233,146-share tax withholding - Stock Titan

Dec 09, 2025

Dec 09, 2025

ADC Therapeutics (ADCT) CMO has 41,068 shares withheld for RSU taxes - Stock Titan

Dec 09, 2025

Dec 09, 2025

ADC Therapeutics (ADCT) CAO reports 7,140 shares withheld for RSU tax and holds 70,757 - Stock Titan

Dec 09, 2025

Dec 09, 2025

ADC Therapeutics (ADCT) CLO Peter Graham reports tax share withholding - Stock Titan

Dec 09, 2025

Dec 09, 2025

ADC Therapeutics (ADCT) CFO reports 53,236-share tax withholding from RSU vesting - Stock Titan

Dec 09, 2025

Dec 09, 2025

ADC Therapeutics (ADCT) files S-3/A Amendment No. 1 to add new auditor consent - Stock Titan

Dec 09, 2025